The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

An international trial identified three new, all-oral drug regimens for drug-resistant tuberculosis, improving treatment ...

A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of ...

Tuberculosis remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant ...

Tuberculosis spreads through germs released when a person with TB in their lungs coughs, speaks or sings. These bacteria can ...

New options make TB treatment faster, safer, and more accessible. A major breakthrough in tuberculosis treatment has emerged: ...

TB infections have been rising every year since 2020 after 30 years of decline. Now, a historic outbreak in Kansas is ...

Researchers reviewed previously published studies to understand trends in multidrug-resistant treatment of TB in children and ...

Studies show under-representation of children and teens with multidrug-resistant TB, calling for focused case-finding efforts ...

As one of the largest tuberculosis outbreaks in the U.S. unfolds in Kansas, UC San Diego researchers and their colleagues ...